Blog
RSS FeedPosted by Michael Wonder on 09 Dec 2019
China to strengthen medicine price monitoring
9 December 2019 - China's National Healthcare Security Administration has issued a guideline to strengthen regular supervision on medicine prices. ...
Posted by Michael Wonder on 05 Dec 2019
How China’s new drug buying program is causing pain
6 December 2019 - China is overhauling its health-care system with the aim of providing broader access to quality drugs for ...
Posted by Michael Wonder on 02 Dec 2019
China updates drug reimbursement list, agrees price cuts
2 December 2019 - Drugs added include AbbVie's Humira and Roche's Perjeta. ...
Posted by Michael Wonder on 02 Dec 2019
National Medical Products Administration approves Chipscreen Bioscience's chidamide (Epidaza) for breast cancer indication
29 November 2019 - Shenzhen Chipscreen Biosciences announced that the company's lead innovative product Epidaza (chidamide), an oral subtype-selective histone ...
Posted by Michael Wonder on 28 Nov 2019
Sosei Heptares announces that the COPD treatment Ultibro Breezhaler has been included in the National Reimbursement Drug List in China
28 November 2019 - Sosei Group announces that Ultibro Breezhaler (an inhaled once-daily fixed-dose combination of indacaterol/glycopyrronium bromide) has been included ...
Posted by Michael Wonder on 28 Nov 2019
Tyvyt (sintilimab Injection), an innovative PD-1 inhibitor jointly developed by Innovent and Lilly, is included in the new catalogue of National Reimbursement Drug List
27 November 2019 - Innovent Biologics today jointly announced with Eli Lilly and Company that the innovative PD-1 inhibitor Tyvyt (sintilimab ...
Posted by Michael Wonder on 28 Nov 2019
Chi-Med’s Elunate (fruquintinib capsules) included in the National Reimbursement Drug List in China
28 November 2019 - Hutchison China MediTech today announces that Elunate (fruquintinib capsules), its national class 1 targeted anticancer drug for ...
Posted by Michael Wonder on 28 Nov 2019
Drug makers including Roche and Novartis slash medicine prices in China to get on reimbursement list
28 November 2019 - Drug makers including Roche and Novartis have agreed to cut the prices of some of their ...
Posted by Michael Wonder on 27 Nov 2019
Astellas announces the approval of Xtandi (enzalutamide) by the China National Medical Products Administration approval based on Asian PREVAIL study of men with metastatic castration-resistant prostate cancer
26 November 2019 - Astellas Pharma today announced that the China National Medical Products Administration approved a new drug application ...
Posted by Michael Wonder on 27 Nov 2019
Merck’s Keytruda (pembrolizumab) now approved in China for first-line treatment of metastatic squamous non-small cell lung cancer in combination with chemotherapy
26 November 2019 - Third approval for Keytruda in first-line NSCLC in China in less than one year. ...
Posted by Michael Wonder on 20 Nov 2019
China to promote centralised medicine procurement, use to ease patients' burden
20 November 2019 - China will improve its mechanism for centralized medicine procurement and use in a steady and orderly ...
Posted by Michael Wonder on 11 Nov 2019
China’s drug market is opening up
11 November 2019 - Beijing’s health-care reforms are giving global pharmaceutical companies better access to the world’s second-largest drug market. ...
Posted by Michael Wonder on 30 Oct 2019
Mapping of health technology assessment in China: situation analysis and international comparison
28 October 2019 - Chen and colleagues have analysed the current development of HTA in China and to identify areas ...
Posted by Michael Wonder on 29 Oct 2019
In generic drug plants in China and India, data falsification is still a problem
29 October 2019 - As the generic drug industry faces allegations of data manipulation, headlines about carcinogen-tainted blood pressure medicine, ...
Posted by Michael Wonder on 26 Oct 2019
Dialogue with Chinese authorities on medicine regulation
25 October 2019 - The Deputy Commissioner of the Chinese National Medical Product Administration, Dr Chen Shifei, visited EMA on ...